216 Basic Ethical Principles in Critical Care
Goals of Care and Medical Decision Making
Surrogate Decision Making
Modern medicine has embraced the concept of shared decision making between patients and their physicians based on the principle of autonomy.1,2 This approach is often more complicated in the intensive care unit (ICU), because patients are frequently too ill or otherwise impaired to make meaningful contributions to decisions about their care. Increasingly, decisions are made in the ICU to withdraw care,3 and conflicts are common between physicians’ practices and patients’ wishes.4 In the ICU, as in other medical situations, patients have an ethical (and in many places, a legal) right to determine the goals of their medical care. An individual patient’s wishes regarding future care in the case of his or her incapacity may be made known in advance of a serious medical illness. The process by which patients, with or without the assistance and participation of their physicians, family members, or other close personal relations, plan for future medical care is called advance care planning.5 In general, the results of these deliberations are known as advance directives; defined broadly, they may be verbal or written and may be quite specific or very general. In this process, the patient determines what kind of care he or she would want in the setting of some hypothetical (or anticipated) situation and makes known his or her wishes regarding future medical care. The advance directive helps direct medical care in case of the patient’s incapacity and comes into play only if the patient is unable to make his or her current wishes known.6 For example, a patient who awakens after a surgical procedure and is deemed competent (see later) is asked outright about his or her wishes, and the advance directive is no longer necessary.
Advance directives have ethical authority in whatever form (including verbal), as long as the directive was promulgated within the requirements of informed consent (see later). Unfortunately, the reliability of a specific advance directive as “authentic representations of autonomous patient choices” is often suspect.7 Advance directives specific enough to guide day-to-day clinical decision making in the ICU are rare; more commonly, the ICU physician is left to work with a surrogate to make decisions for a patient who is too sick to participate in decisions.
In some cultures, physicians often turn to the “next of kin” for surrogate decision making. However, the legal status of surrogates varies from country to country, and this individual may have no legal or ethical grounds for assuming this role. Even in cultures in which surrogate decision making is valued, there is often no designated hierarchy of surrogates. In those cultures in which such a hierarchy has been determined by law, a typical sequence might be (1) spouse, (2) eldest child, (3) next child, (4) parent, (5) sibling. In addition to legal standing, the surrogate should have some moral standing to act as such. For example, a surrogate specifically named in an advance directive document or verbally designated by the patient as the preferred surrogate would have this standing. In fact, some would argue that this is the single most important question for a patient who is sick enough to warrant ICU care (“If you become too sick to speak for yourself, who would you want to make medical decisions for you?”).8 In surveys about advance directives and surrogates, patients and well individuals typically name their spouses or other immediate family members as their preferred surrogates. These individuals frequently (though not always) have a shared value system. Interestingly, when asked whether they would prefer that their advance directives be followed no matter what or that their care be discussed with their chosen surrogate, a majority of patients would cede authority to the surrogate.9
Advance Directives
Additionally, a number of advisory documents have been developed, including “values histories” and the medical directive developed by Linda and Ezekiel Emanuel.10 These documents may present a series of increasingly dire scenarios and ask about overall preferences (“do everything possible to prolong life,” “continue aggressive care but reevaluate often,” “keep me comfortable, but do not provide care that prolongs my life”), or they may ask more general questions about what makes the person’s life “worth living.” It is hoped that this information will be helpful to a surrogate who must decide whether to continue supportive care in the case of irreversible injury or damage or even to continue disease-oriented care in the case of critical illness and impaired decision-making capacity.
For a variety of reasons, advance directives have not achieved wide popularity. When they exist, they are often not specific enough to provide meaningful guidance.11 Even when a detailed directive exists, a question often remains about whether the individual was adequately informed. For example, a patient’s advance directive says that she would never want to be on “life support,” but when she is asked about mechanical ventilation in the case of reversible respiratory failure from pneumonia, she says of course she would want that. Thus, following a legally executed advance directive without verifying what was meant by the patient and whether the written wishes apply to the current illness is often quite problematic. It could in fact result in a preventable death in a patient who, with proper education, would wish to be treated.
A more limited form of advance directive, known as a code status, is sometimes sought on admission to the hospital, and especially on admission to the ICU. A code status is an advance directive that is specifically limited to a patient’s (or surrogate’s) preferences regarding cardiopulmonary resuscitation (CPR) and other measures in the event of cardiopulmonary arrest. In many hospitals and other healthcare institutions, as a matter of policy, any patient who suffers cardiac arrest is treated with interventions designed to attempt to reverse the life-threatening derangement, including CPR, electrical defibrillation, and intubation and mechanical ventilatory support. Because a patient who suffers a cardiopulmonary arrest will die in a very short time without interventions, the discussion about code status is as much about how a patient wishes to die as it is about whether he or she wishes to live. Tomlinson and Brody distinguish three distinct rationales for a do-not-resuscitate (DNR) status12: (1) CPR has such a low likelihood of producing the desired outcome that it is effectively “futile,” (2) there would be an unacceptable quality of life after CPR, and (3) there is already an unacceptable quality of life, and cardiopulmonary arrest would be a welcome deliverance. A decision about CPR may not give much useful information about a patient’s preferences regarding other aspects of his or her illness. A patient may choose aggressive disease-oriented measures well into a severe illness but still choose to forgo resuscitation in the event of an arrest. This approach may be voiced in a statement such as, “I want to fight this thing with all I have, but when it is my time, I want to go quickly without suffering.” Such a statement would be an opportunity to address resuscitation status, in addition to addressing overall goals of care (see later).
Any discussion of advance directives should attempt to answer at least three questions: (1) In the event of cardiac arrest, do you want the healthcare team to attempt resuscitation? (2) If you become incapacitated, who do you want to make decisions for you? (3) If you were left significantly impaired after an attempt at resuscitation, would you want us to discontinue life-sustaining care? Preferences for resuscitation are best understood in the context of an individual’s values, beliefs, relationships, and culture.7
Informed Decision Making (Informed Consent)
Brock discussed the basic requirements for informed consent and identified three critical elements: the person giving consent must be competent, informed, and able to make a decision free from coercion.13 Competence has several critical elements.14 First, the decision maker must be capable of understanding relevant information, which involves both memory and mental processing. Second, it requires the ability to attend to and retain information, the ability to manipulate information, and the ability to foresee consequences. A third element is the ability to formulate and communicate choice. Some standards of competency strengthen this requirement by demanding the ability to communicate a stable choice (in this case, ambivalence may be a sign of incompetence).
To adequately participate in medical decision making, patients must have enough information to weigh the risks and benefits of various medical interventions. In the past, the standard for being “informed” was the standard practice of other physicians in the community.15 Subsequently, “informed” came to mean what a “reasonable person would want to know.” Because the main point of informed consent is to respect the rights and values of individuals, it is most appropriate to address this issue in terms of what a particular patient needs to know.16 In general, patients need to know about the illness and its natural history to make informed decisions about medical care. They need information about the effectiveness of treatment, the risks of treatment, and the likelihood of success with treatment. This information must be presented in a way that is understandable to the patient, at an appropriate educational level, and in the patient’s language. Whether enough information has been transmitted can be assessed at the most basic level by simply asking a patient whether he or she has any questions. Brock writes of “informed understanding” and notes that this “permits an informed exercise in self-determination and promotes a decision most in accord with the patient’s well-being.”13 In addition, this approach values autonomy.
The adequacy of a properly designated surrogate is usually assumed but should be questioned in two situations. The first is when the surrogate acts in contrast to the patient’s known wishes. Anyone who knows that the surrogate’s directions conflict with the patient’s expressed wishes has an obligation to work with the surrogate to come to a treatment decision more in keeping with the patient’s wishes or to seek outside assistance from the hospital ethics committee or the hospital’s legal department. The second situation occurs when there is doubt about the surrogate’s competence, specifically his or her ability to retain and process information. Again, the ethics committee or the risk management department can be of help in this situation. An important study by Schneiderman et al.17 demonstrated the value of ethics consultation for ICU patients. In that randomized controlled trial, patients receiving an ethics consultation had shorter ICU and hospital stays as well as a decrease in the use of “non-beneficial treatments.” This study has led to a call in the literature for more frequent utilization of ethics consultations in the ICU.18–20
Key Points
Applebaum PS, Grisso T. Assessing patients’ capacities to consent to treatment. N Engl J Med. 1988;319:1635-1638.
Brock DW. Informed consent. In: Regan T, VanDeVeer D, editors. Health care ethics. Philadelphia: Temple University Press; 1987:98-126.
Brock DW. Surrogate decision making for incompetent adults: an ethical framework. Mt Sinai J Med. 1991;58:388-392.
An excellent overview of a philosophically sound approach to surrogate decision making.
Burns JP, Edwards J, Johnson J, Cassem NH, Truog RD. Do-not-resuscitate order after 25 years. Crit Care Med. 2003;31:1543-1550.
Cantor NL. My annotated living will. Law Med Health Care. 1990;18:115-119.
This is an excellent example of an annotated advance directive.
Prendergast T. Advance care planning: pitfalls, progress, promise. Crit Care Med. 2001;29:N34-N39.
Schneiderman LJ, Gilmer T, Teetzel HD, Dugan DO, Blustein J, Cranford R, et al. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA. 2003;290:1166-1172.
1 Carmi A, editor. UNESCO Chair in Bioethics: Informed Consent. Israel National Commission for UNESCO, 2003.
2 Beauchamp TL, Childress JF. Respect for autonomy. In: Principles of biomedical ethics, 5th ed. New York: Oxford University Press; 2001.
3 Prendergast TL, Luce JM. Increased incidence of withholding and withdrawal of life support from the critically ill. Am J Respir Crit Care Med. 1996;154:15-20.
4 Asch DA, et al. Decisions to limit or continue life-sustaining treatment by critical care physicians in the United States: Conflict between physicians’ practices and patients’ wishes. Am J Respir Crit Care Med. 1995:288-292.
5 Emanuel LL, et al. Advance care planning. Arch Fam Med. 2000;9:1181-1187.
6 Teno JM, Lynn J. Putting advance-care planning into action. J Clin Ethics. 1996;7:205-214.
7 Puchalski CM, et al. Patients who want their family and physician to make resuscitation decisions for them: Observations from SUPPORT and HELP. J Am Geriatr Soc. 2000;48:S84-S90.
8 Mappes TA. Some reflections on advance directives. In: Mappes TA, Degrazia D, editors. Biomedical ethics. 5th ed. New York: McGraw-Hill; 2001:356-363.
9 Layde PM, et al. Surrogates’ predictions of seriously ill patients’ resuscitation preferences. Arch Fam Med. 1995;4:518-523.
10 Emanuel LL. Advance directives: What have we learned so far? J Clin Ethics. 1993;4:8-16.
11 Dresser RS. Autonomy revisited: the limits of anticipatory choices. In: Hackler C, Moseley R, Vawter DE, editors. Advance directives in medicine. New York: Praeger; 1989:71-85.
12 Tomlinson T, Brody H. Ethics and communication in do-not-resuscitate orders. N Engl J Med. 1988;318:43-46.
13 Brock D. Informed consent. In: Regan T, VanDeVeer D, editors. Health care ethics. Philadelphia: Temple University Press; 1987:98-126.
14 Applebaum PS, Grisso T. Assessing patients’ capacities to consent to treatment. N Engl J Med. 1988;319:1635-1638.
15 Gild WM. Informed consent: A review. Anesth Analg. 1989;68:649-653.
16 The values underlying informed consent, from the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. In: Mappes TA, Degrazia D, editors. Biomedical ethics. 5th ed. New York: McGraw-Hill; 2001:97-103.
17 Schneiderman LJ, Gilmer T, Teetzel HD, Dugan DO, Blustein J, Cranford R, et al. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA. 2003;290:1166-1172.
18 Truog R, Campbell M, Curtis JR, Haas C, Luce J, Rubenfeld G, et al. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College of Critical Care Medicine. Crit Care Med. 2008;36:953-963.
19 Schneiderman L. Ethics consultation in the intensive care unit. Curr Opin. Intern Med. 2006;5:79-83.
20 Romano M, Wahlander S, Lang B, Li G, Prager KM. Mandatory ethics consultation policy. Mayo Clinic Proc. 2009;84:581-585.